Enclomiphene - Beligas

Enclomiphene, manufactured by Beligas, contains pharmaceutical grade Enclomiphene Citrate supplied in a verified 50 pills x 12.5 mg presentation.

Enclomiphene belongs to the SERM (Post Cycle Therapy) class and features an active half life of 5-7 days. Every batch undergoes strict quality control verification to ensure consistent concentration, purity, and reliable bioavailability throughout your protocol.

Primary benefits of Enclomiphene:

        Supports high quality lean tissue development and physical performance;
        Manufactured under strict pharmaceutical standards by Beligas;
        Consistent release profile with predictable half life kinetics (5-7 days);
        Verified batch purity and sterile packaging integrity.

Recommended administration and cycle guidelines:

Standard protocols for Enclomiphene utilize a dosage range of 50 mg/day depending on individual experience and cycle objectives. Users should always monitor health markers and follow structured post cycle recovery guidelines when applicable.

Storage and handling:

Keep Enclomiphene in its original protective carton away from direct sunlight, moisture, and heat sources.